\
&
Contact us
\
&
Contact us
This was 3 weeks ago
LocationBrussels
The event gathers European security leaders, researchers, and practitioners to explore the theme of shaping responsible solutions for internal security. It aims to foster discussions on how innovation can be responsibly harnessed in various areas while ensuring transparency and fundamental rights.
This full-day event will feature experts discussing technology and policy intersections, including topics such as artificial intelligence, biometrics, cybersecurity, and digital investigations. Attendees will have the opportunity to network and share insights on the future of internal security and technological solutions.
The agenda is available here, for registration please follow this link
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
